Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Harrison

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|May 16, 2022
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapyAdam H Lapidus, Mary Ann Anderson, Simon J Harrison, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation TherapiesChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Expert Review of Hematology|March 17, 2021
Paving the way to precision medicine in multiple myelomaShafqat Inam, Jeremy A Ross, Cyrille Touzeau, et al.
Urology Annals|December 23, 2015
Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literatureMunad Khan, Nieroshan Rajarubendra, Sarah Azer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2016
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysisBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
Thrombosis Research|May 7, 2013
Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptideMark J Bishton, Elizabeth E Gardiner, Simon J Harrison, et al.
The Lancet. Oncology|February 3, 2020
Levofloxacin prophylaxis in patients with myelomaBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 22, 2023
Listening to What Matters Most: Consumer Endorsed Patient Reported Outcome Measures (PROMs) for Use in Multiple Myeloma Clinical Trials: A Descriptive Exploratory StudyHayley Beer, Holly Chung, Simon J Harrison, et al.
Blood Cancer Journal|March 9, 2023
Infectious complications of bispecific antibody therapy in patients with multiple myelomaBeatrice Z Sim, Anthony Longhitano, Jeremy Er, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|May 16, 2022
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapyAdam H Lapidus, Mary Ann Anderson, Simon J Harrison, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2021
Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation TherapiesChhay Lim, Priyadarshini Sinha, Simon J Harrison, et al.
Expert Review of Hematology|March 17, 2021
Paving the way to precision medicine in multiple myelomaShafqat Inam, Jeremy A Ross, Cyrille Touzeau, et al.
Urology Annals|December 23, 2015
Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literatureMunad Khan, Nieroshan Rajarubendra, Sarah Azer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2016
Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysisBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Pathology|March 9, 2021
CAR-T cell therapy: practical guide to routine laboratory monitoringAdrian G Selim, Adrian Minson, Piers Blombery, et al.
Thrombosis Research|May 7, 2013
Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptideMark J Bishton, Elizabeth E Gardiner, Simon J Harrison, et al.
The Lancet. Oncology|February 3, 2020
Levofloxacin prophylaxis in patients with myelomaBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 22, 2023
Listening to What Matters Most: Consumer Endorsed Patient Reported Outcome Measures (PROMs) for Use in Multiple Myeloma Clinical Trials: A Descriptive Exploratory StudyHayley Beer, Holly Chung, Simon J Harrison, et al.
Blood Cancer Journal|March 9, 2023
Infectious complications of bispecific antibody therapy in patients with multiple myelomaBeatrice Z Sim, Anthony Longhitano, Jeremy Er, et al.
Pageof 16